Biohippo Inc. Partners with c-LEcta: Elevating the DENARASE® Supply Chain in the USA
We're thrilled to announce our new partnership with c-LEcta, a premier global biotechnology company. This collaboration signifies a substantial leap forward in our continuous effort to make DENARASE® products even more accessible to the US market.
With this partnership
Enhanced Availability: We've ensured that R&D-grade DENARASE® products will now be available directly from our local warehouse in Gaithersburg, Maryland. This streamlines the process, offering quicker deliveries and no hassles with customs clearances, guaranteeing smooth access for all R&D projects.
Simplified Ordering: Beyond overseeing the warehouse logistics, Biohippo is also taking on the mantle of the official distributor for all DENARASE® products. This step dovetails with our objective to refine and simplify the research experience for our esteemed clientele.
This collaboration between Biohippo and c-LEcta stems from our shared aspiration to fortify a robust and efficient supply chain. Our clients stand to reap numerous benefits, most notably significantly expedited delivery times and an uncomplicated ordering process.
The synergies between Biohippo and c-LEcta come at a crucial time, aligning with c-LEcta's strategic emphasis on the expanding US biopharma arena. DENARASE®, an endonuclease enzyme pivotal for degrading unnecessary DNA and RNA during biopharmaceutical manufacturing processes, has been an integral component of c-LEcta's success story in the USA.
Positioned at the cutting edge of life science research facilitation, Biohippo Inc., based in Gaithersburg, Maryland, is laser-focused on equipping researchers with hassle-free access to essential research tools and resources. Our comprehensive online platform showcases a rich array of life science research products and services sourced from multiple providers. Moreover, our unparalleled capability in procuring rare and specialized items solidifies our standing in the industry.
For a deeper dive into our diverse offerings and our transformative role in the life science research ecosystem, visit www.ebiohippo.com.
c-LEcta is a global biotechnology company specializing in the development, production and distribution of enzyme products. The company uses world-class enzyme engineering and production technologies to provide its partners in the food and pharmaceutical industries with superior biotechnological solutions for innovative industrial applications. Product development is based on the proprietary enzyme technology platform ENESYZ® and is carried out both in-house and in close cooperation with industry partners worldwide. c-LEcta supplies its products to more than 400 customers in over 40 countries.
c-LEcta is part of the Kerry Group. Kerry is the world’s leading taste and nutrition partner for the food, beverage and pharmaceutical markets. The company employs 22,000 people across over 150 locations and uses its broad range of ingredient solutions to innovate with its customers and create great tasting products, with improved nutrition and functionality, while ensuring a better impact for the planet.
More about DENARASE®
This entry was posted in News